The prefilled, patient-ready-to-use system is said to support delivery of high-viscosity biologics of up to 50 centipoise.

Franklin Lakes, New Jersey Thursday, July 24, 2025, 14:00 Hrs [IST] ...

Becton Dickinson (BDX) announced the first pharma-sponsored combination product clinical trial using the BD Libertas Wearable Injector for ...

Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership ...

BD (NYSE:BDX) today announced the first pharma-sponsored combination product clinical trial using its wearable injector technology.

FRANKLIN LAKES, N.J., Dec. 9, 2020 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced publication of the results from a 52-subject human ...

GOTHENBURG, Sweden, February 11, 2020 / B3C newswire / --BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the completion of a 50-subject human clinical ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable ...

BD (Becton, Dickinson and Company), a global medical technology company, has announced the completion of a 50-subject human clinical trial with the BD Libertas™ Wearable Injector. The injector is a ...

FRANKLIN LAKES, N.J., Dec. 9, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced publication of the results from a 52 ...

--BD, a leading global medical technology company, today announced publication of the results from a 52- subject human clinical trial with the BD Libertas™ Wearable Injector. The subcutaneous ...